ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 865 filers reported holding ISHARES TR in Q4 2023. The put-call ratio across all filers is 4.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $43,420 | -40.4% | 316 | -40.5% | 0.00% | -50.0% |
| Q1 2024 | $72,910 | +12.8% | 531 | +11.6% | 0.00% | 0.0% |
| Q4 2023 | $64,665 | -7.6% | 476 | -16.8% | 0.00% | 0.0% |
| Q3 2023 | $69,950 | -96.3% | 572 | -96.1% | 0.00% | -96.6% |
| Q2 2023 | $1,876,596 | +5.3% | 14,781 | +7.2% | 0.12% | 0.0% |
| Q1 2023 | $1,781,504 | +2.1% | 13,793 | +3.8% | 0.12% | -1.7% |
| Q4 2022 | $1,744,713 | +137.1% | 13,289 | +111.1% | 0.12% | +98.4% |
| Q3 2022 | $736,000 | +2966.7% | 6,296 | +3032.3% | 0.06% | +2950.0% |
| Q2 2022 | $24,000 | -7.7% | 201 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $26,000 | -45.8% | 201 | -36.2% | 0.00% | -50.0% |
| Q4 2021 | $48,000 | +23.1% | 315 | +31.2% | 0.00% | 0.0% |
| Q3 2021 | $39,000 | +18.2% | 240 | +19.4% | 0.00% | 0.0% |
| Q2 2021 | $33,000 | +10.0% | 201 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $30,000 | 0.0% | 201 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $30,000 | +11.1% | 201 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $27,000 | 0.0% | 201 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $27,000 | +22.7% | 201 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $22,000 | -8.3% | 201 | 0.0% | 0.01% | -25.0% |
| Q4 2019 | $24,000 | +20.0% | 201 | 0.0% | 0.01% | -20.0% |
| Q3 2019 | $20,000 | -58.3% | 201 | -54.5% | 0.01% | -65.5% |
| Q2 2019 | $48,000 | -2.0% | 442 | 0.0% | 0.03% | +20.8% |
| Q1 2019 | $49,000 | +16.7% | 442 | 0.0% | 0.02% | +14.3% |
| Q4 2018 | $42,000 | -27.6% | 442 | -6.9% | 0.02% | -38.2% |
| Q3 2018 | $58,000 | +11.5% | 475 | 0.0% | 0.03% | +6.2% |
| Q2 2018 | $52,000 | -95.0% | 475 | -95.2% | 0.03% | -94.6% |
| Q1 2018 | $1,032,000 | +7.1% | 9,906 | +9.7% | 0.60% | -3.4% |
| Q4 2017 | $964,000 | -12.7% | 9,028 | +177.6% | 0.62% | -24.4% |
| Q3 2017 | $1,104,000 | +10.5% | 3,252 | +0.9% | 0.82% | +27.5% |
| Q2 2017 | $999,000 | 0.0% | 3,222 | -5.4% | 0.64% | -3.6% |
| Q1 2017 | $999,000 | +5.4% | 3,407 | -4.6% | 0.66% | +3.6% |
| Q4 2016 | $948,000 | – | 3,572 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |